Market
New area of cooperation in U.S.-China relations highlighted by mid-2025?
2
Resolution / Starting Odds
Space Exploration • 25%
Healthcare • 25%
Artificial Intelligence • 25%
Other • 25%
Official announcements from the U.S. or Chinese government, or credible news sources
Story
Xi Jinping Sends Han Zheng to Trump's Inauguration for First Time
Jan 17, 2025, 03:38 AM
Chinese President Xi Jinping will not attend the inauguration of U.S. President-elect Donald Trump on January 20, but he has designated Vice President Han Zheng as his special representative to attend the ceremony in Washington, D.C. The decision was announced by the Chinese Foreign Ministry, indicating China's readiness to enhance dialogue and communication with the new U.S. administration. This move marks the first time a senior Chinese leader will attend a U.S. presidential inauguration, signaling Beijing's intent to manage differences and expand cooperation with the U.S. to foster stable, healthy, and sustainable bilateral relations.
View original story
Similar markets
Automotive • 25%
Healthcare • 25%
Finance • 25%
Technology • 25%
Climate • 25%
Trade • 25%
Technology • 25%
Other • 25%
Military tensions • 25%
Human rights issues • 25%
Technology competition • 25%
Trade negotiations • 25%
Technology • 25%
Trade • 25%
Regional Stability • 25%
Other • 25%
Technology • 25%
Other • 25%
Military • 25%
Trade • 25%
Technological development • 25%
Economic cooperation • 25%
Health and pandemic response • 25%
Cultural exchange • 25%
Climate Policy • 25%
Human Rights • 25%
Technology • 25%
Trade Policy • 25%
Security and defense • 25%
Health and pandemics • 25%
Trade • 25%
Climate change • 25%
Taiwan relations • 25%
Trade relations • 25%
Military cooperation • 25%
Climate change • 25%
Artificial Intelligence and Robotics • 25%
Space Exploration • 25%
Climate Change and Environmental Science • 25%
Biomedical Research • 25%
Artificial Intelligence • 25%
Space Exploration • 25%
Public Health • 25%
Climate Change • 25%
Regional stability and security • 25%
Trade • 25%
Other • 25%
Fentanyl and drug control • 25%